Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3432652 | 0.79 | LMNA (0.54) | LMNAALDH1A1ALOX15CYP1B1TSHR | |
| SCHEMBL8486388 | 0.77 | LMNA (0.47) | LMNAALDH1A1ALOX15CYP1B1TSHR | |
| SCHEMBL13280678 | 0.77 | LMNA (0.37) | LMNAALDH1A1ALOX15CYP1B1TSHR | |
| SCHEMBL11103446 | 0.76 | LMNA (0.42) | LMNAALDH1A1ALOX15CYP1B1TSHR | |
| SCHEMBL9129884 | 0.76 | — | — | |
| SCHEMBL513994 | 0.76 | — | — | |
| Ethylene SCHEMBL4704387 | 0.75 | LMNA (0.45) | LMNAALDH1A1ALOX15CYP1B1TSHR | |
| SCHEMBL20054315 | 0.74 | ESR2 (0.35) | LMNAESR2 | |
| SCHEMBL24208353 | 0.72 | LMNA (0.38) | LMNAALDH1A1ALOX15CYP1B1TSHR | |
| SCHEMBL27813655 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260033489-A1 | NANOSYSTEMS BASED ON NANOCOMPOSITES AND NATURAL EXTRACTS | LOPEZ MACIAS JAVIER EDUARDO (MX) | 2026-02-05 | — | — | US | claimed |
| WO-2025242522-A1 | BIOPESTICIDE COMPOSITION, PROCEDURE OF OBTAIN THEREOF, AND METHOD FOR CONTROLLING AND TREATING BROAD SPECTRUM OF PESTS, DISEASES AND WEEDS IN PLANTS | Kimitec Biogroup S.L. (ES) | 2025-11-27 | — | — | WO | claimed |
| EP-4652842-A1 | BIOPESTICIDE COMPOSITION, PROCEDURE OF OBTAIN THEREOF, AND METHOD FOR CONTROLLING AND TREATING BROAD SPECTRUM OF PESTS, DISEASES AND WEEDS IN PLANTS | Kimitec Biogroup S.L (ES) | 2025-11-26 | — | — | EP | claimed |
| US-12478063-B2 | Nanosystems based on nanocomposites and natural extracts | LÓPEZ MACÍAS, Javier Eduardo (MX) | 2025-11-25 | — | — | US | claimed |
| WO-2024126672-A1 | BIOPESTICIDE COMPOSITION AND METHOD FOR CONTROLLING AND TREATING BROAD SPECTRUM OF PESTS AND DISEASES IN PLANTS | Kimitec Biogroup S.L (ES) | 2024-06-20 | — | — | WO | claimed |
| EP-4385327-A1 | BIOPESTICIDE COMPOSITION AND METHOD FOR CONTROLLING AND TREATING BROAD SPECTRUM OF PESTS AND DISEASES IN PLANTS | Kimitec Group S.L. (ES) | 2024-06-19 | — | — | EP | claimed |
| EP-4385326-A1 | BIOPESTICIDE COMPOSITION AND METHOD FOR CONTROLLING AND TREATING BROAD SPECTRUM OF PESTS AND DISEASES IN PLANTS | Kimitec Biogorup (ES) | 2024-06-19 | — | — | EP | claimed |
| US-20240041027-A1 | NANOSYSTEMS BASED ON NANOCOMPOSITES AND NATURAL EXTRACTS | LÓPEZ MACÍAS, Javier Eduardo (MX) | 2024-02-08 | — | — | US | claimed |
| CN-117007705-A | Atractylodes lancea origin tracing method based on machine learning algorithm of HS-GC-MS and fast GC e-phase technology | 南京中医药大学 | 2023-11-07 | — | — | CN | claimed |
| EP-4260706-A1 | NANOSYSTEMS BASED ON NANOCOMPOSITES AND NATURAL EXTRACTS | López Macías, Javier Eduardo (MX) | 2023-10-18 | — | — | EP | claimed |
| CN-115166068-B | Temperature-internal medicine sharing and differential volatile component analysis based on headspace-gas chromatography-ion mobility spectrometry | 山东省中医药研究院 | 2023-08-25 | — | — | CN | claimed |
| CN-115166068-A | Warm-interior medicine sharing and difference volatile component analysis based on headspace-gas chromatography-ion mobility spectrometry | 山东省中医药研究院 | 2022-10-11 | — | — | CN | claimed |
| WO-2022129983-A1 | NANOSYSTEMS BASED ON NANOCOMPOSITES AND NATURAL EXTRACTS | LÓPEZ MACÍAS, Javier Eduardo (MX) | 2022-06-23 | — | — | WO | claimed |
| CN-113577115-B | Application of golden tea volatile oil in preparation of LPS (lipopolysaccharide) induced acute lung injury protection medicine | 南昌大学 | 2022-04-12 | — | — | CN | claimed |
| US-5587354-A | MIXTURE OF A TERPENE AND OIL | INTEGRITY INDUSTRIES, INC. (US) | 1996-12-24 | — | — | US | claimed |
| US-20260101926-A1 | VAPORIZING DEVICE | MINSKOFF NOAH MARK (US) | 2026-04-16 | — | — | US | disclosed |
| US-20260033489-A1 | NANOSYSTEMS BASED ON NANOCOMPOSITES AND NATURAL EXTRACTS | LOPEZ MACIAS JAVIER EDUARDO (MX) | 2026-02-05 | — | — | US | disclosed |
| US-5587354-A | MIXTURE OF A TERPENE AND OIL | INTEGRITY INDUSTRIES, INC. (US) | 1996-12-24 | — | — | US | disclosed |
| US-5559085-A | IMPROVED BIODEGRADATION | INTEGRITY INDUSTRIES, INC. (US) | 1996-09-24 | — | — | US | disclosed |
| US-5547925-A | Low toxicity terpene drilling fluid and drilling fluid additive | INTEGRITY INDUSTRIES, INC. (US) | 1996-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260101926-A1 | VAPORIZING DEVICE | SARAF, HSF1, TFPI | LMNA 1476/4885ALDH1A1 3793/4885ALOX15 4383/4885 |
| US-20260033489-A1 | NANOSYSTEMS BASED ON NANOCOMPOSITES AND NATURAL EXTRACTS | SOD3, RPS3, CD63 | LMNA 1701/4885ALDH1A1 2375/4885ALOX15 616/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.